Grant: Cancer Research Society Doctoral Research Awards - CBCI
University of Toronto
$35,000.00
Evaluating PARP Inhibitors for Primary Breast Cancer Prevention
FY 2026-27
Summary
This project focuses on breast cancer. The purpose of this project is to ultimately provide alternate chemoprevention options for high-risk breast cancer patients. Its focus is to develop targeted therapies to ablate the breast cancer precursor cells, to prevent tumorigenesis. Despite significant advances in screening, diagnosis and treatment for high-risk populations, there remains limited prevention options. This project will use human patient-derived breast tissue samples, supplemented by murine mammary gland research work. I will use advanced technologies such as proteomics and imaging to uncover new targets and drug candidates for therapeutic breast cancer intervention. Ultimately, this research will contribute to novel, effective prevention treatments to improve breast cancer patient's lives. 1 in 8 females are diagnosed with breast cancer, making it a leading cause of cancer. Given the unfortunately high impact of breast cancer on patients, it is most important to advance this field to reduce mortality rates and improving the quality of life of patients.
Department
Program
Cancer Research Society Doctoral Research Awards - CBCI
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
580351
Name
Drummond Guy Olivia L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Evaluating PARP Inhibitors for Primary Breast Cancer Prevention
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Toronto
Cihramount2
$35,000
Cihrequipment2
$0
Programname2
Cancer Research Society Doctoral Research Awards - CBCI
Keyworddelim
Cancer
Abstract
This project focuses on breast cancer. The purpose of this project is to ultimately provide alternate chemoprevention options for high-risk breast cancer patients. Its focus is to develop targeted therapies to ablate the breast cancer precursor cells, to prevent tumorigenesis. Despite significant advances in screening, diagnosis and treatment for high-risk populations, there remains limited prevention options. This project will use human patient-derived breast tissue samples, supplemented by murine mammary gland research work. I will use advanced technologies such as proteomics and imaging to uncover new targets and drug candidates for therapeutic breast cancer intervention. Ultimately, this research will contribute to novel, effective prevention treatments to improve breast cancer patient's lives. 1 in 8 females are diagnosed with breast cancer, making it a leading cause of cancer. Given the unfortunately high impact of breast cancer on patients, it is most important to advance this field to reduce mortality rates and improving the quality of life of patients.
Competitiondate
202604
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Drummond Guy, Olivia L
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $35,000~ $0~